HK1098378A1 - Neutrophilia inhibitor - Google Patents

Neutrophilia inhibitor

Info

Publication number
HK1098378A1
HK1098378A1 HK07104941.5A HK07104941A HK1098378A1 HK 1098378 A1 HK1098378 A1 HK 1098378A1 HK 07104941 A HK07104941 A HK 07104941A HK 1098378 A1 HK1098378 A1 HK 1098378A1
Authority
HK
Hong Kong
Prior art keywords
neutrophilia
inhibitor
neutrophilia inhibitor
Prior art date
Application number
HK07104941.5A
Other languages
English (en)
Inventor
Takehisa Iwama
Nobutomo Tsuruzoe
Original Assignee
Nissan Chemical Ind Ltd
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd, Taisho Pharmaceutical Co Ltd filed Critical Nissan Chemical Ind Ltd
Publication of HK1098378A1 publication Critical patent/HK1098378A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK07104941.5A 2003-12-26 2007-05-09 Neutrophilia inhibitor HK1098378A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003433747 2003-12-26
PCT/JP2004/019199 WO2005063250A1 (ja) 2003-12-26 2004-12-22 好中球増多抑制剤

Publications (1)

Publication Number Publication Date
HK1098378A1 true HK1098378A1 (en) 2007-07-20

Family

ID=34736527

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104941.5A HK1098378A1 (en) 2003-12-26 2007-05-09 Neutrophilia inhibitor

Country Status (13)

Country Link
US (2) US20070117806A1 (ja)
EP (1) EP1698339A4 (ja)
JP (1) JP4688681B2 (ja)
KR (2) KR20060125816A (ja)
CN (1) CN1897952B (ja)
AU (1) AU2004308806B9 (ja)
BR (1) BRPI0417200A (ja)
CA (1) CA2549672C (ja)
HK (1) HK1098378A1 (ja)
IL (1) IL176473A (ja)
RU (1) RU2356555C2 (ja)
TW (1) TW200522962A (ja)
WO (1) WO2005063250A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101538245B (zh) * 2008-03-18 2011-02-16 中国科学院上海药物研究所 一类哒嗪酮类化合物及其制备方法和制备药物的用途
CN102133217B (zh) * 2010-01-27 2013-07-24 中国科学院上海药物研究所 一类以n为桥键的哒嗪酮类化合物在制备抗肿瘤的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194835T1 (de) * 1990-04-25 2000-08-15 Nissan Chemical Ind Ltd Pyridazinonderivat
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives
ATE307584T1 (de) * 1997-08-28 2005-11-15 Nissan Chemical Ind Ltd Mittel zur förderung und verstärkung der neovaskularisierung
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
RU2229297C2 (ru) * 1998-09-01 2004-05-27 Ниссан Кемикал Индастриз, Лтд. Терапевтический агент для лечения стеноза позвоночного канала
RU2229885C2 (ru) * 1998-12-07 2004-06-10 Ниссан Кемикал Индастриз, Лтд. Средство для лечения нарушения функции эрекции
JP2001131088A (ja) * 1999-11-02 2001-05-15 Kyurin:Kk シンドロームx症候群治療剤

Also Published As

Publication number Publication date
IL176473A (en) 2013-06-27
JP4688681B2 (ja) 2011-05-25
WO2005063250A1 (ja) 2005-07-14
RU2356555C2 (ru) 2009-05-27
TW200522962A (en) 2005-07-16
US20070117806A1 (en) 2007-05-24
IL176473A0 (en) 2006-10-05
AU2004308806B2 (en) 2009-10-29
BRPI0417200A (pt) 2007-02-06
RU2006127040A (ru) 2008-02-10
CA2549672A1 (en) 2005-07-14
CN1897952A (zh) 2007-01-17
EP1698339A4 (en) 2009-06-17
US20080306080A1 (en) 2008-12-11
TWI341729B (ja) 2011-05-11
JPWO2005063250A1 (ja) 2007-07-19
CN1897952B (zh) 2010-12-08
EP1698339A1 (en) 2006-09-06
KR20100019542A (ko) 2010-02-18
CA2549672C (en) 2010-06-22
AU2004308806B9 (en) 2010-01-28
KR20060125816A (ko) 2006-12-06
KR101293350B1 (ko) 2013-08-05
AU2004308806A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
AU306126S (en) Showerhead
EP1660436A4 (en) cathepsin inhibitors
GB0326439D0 (en) Methods
EP1532133A4 (en) NF-: B INHIBITORS
EP1663279A4 (en) MODIFIED PROTEASE INHIBITORS
EP1704142A4 (en) PROTEASE INHIBITORS
GB0328243D0 (en) Methods
GB0311195D0 (en) Glyoxalase inhibitors
HK1098378A1 (en) Neutrophilia inhibitor
GB2384718B (en) Carry curbz
GB0305202D0 (en) Scale inhibitor
EP1627064A4 (en) INHIBITION OF FLOWERING
GB2388638B (en) Hosepipe
GB0327909D0 (en) Methods
GB0327368D0 (en) Methods
GB0320627D0 (en) Methods
GB0315827D0 (en) Methods
GB0307076D0 (en) Methods
GB0312619D0 (en) Complement inhibitors
GB0300607D0 (en) Inhibitors
GB0329869D0 (en) Inhibitors
GB0226149D0 (en) Inhibitors
GB0207488D0 (en) Inhibitors
GB0217330D0 (en) Inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171222